Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Candel Therapeutics (CADL)
NASDAQ:CADL
Candel Therapeutics (CADL) Ownership - Who Owns Candel Therapeutics?
169 Followers
Candel Therapeutics (CADL) Ownership Overview
29.37% Insiders
4.28% Mutual Funds
14.93% Other Institutional Investors
51.41% Public Companies and
Individual Investors
The ownership structure of Candel Therapeutics (CADL) stock is a mix of institutional, retail and individual investors. Approximately 19.22% of the company’s stock is owned by Institutional Investors, 29.37% is owned by Insiders and 51.41% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jul 19, 2024 | xxxxxxxxxxxxx | $96086 | |
| Jul 19, 2024 | xxxxxxxxxxxxx | $70361 | |
| Jul 19, 2024 | Paul Peter Tak Ceo,director | xxxxxxxxxxxxx | $145756 |
| Jul 19, 2024 | Charles Schoch Interim Cfo | xxxxxxxxxxxxx | $63949 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 767,524 | Institution | 2.58% | 4,612,819 | |
| 751,329 | Institution | 2.52% | 4,515,487 | |
| 541,295 | Institution | 1.82% | 3,253,183 | |
| 383,376 | Institution | 1.29% | 2,304,090 | |
| 138,080 | Institution | 0.46% | 829,861 | |
| 133,104 | Institution | 0.45% | 799,955 | |
| 74,895 | Institution | 0.25% | 450,119 | |
| 34,156 | Institution | 0.11% | 205,278 | |
| 10,622 | Institution | 0.04% | 63,838 | |
| 3,521 | Institution | 0.01% | 21,161 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 541,295 | Institution | 1.82% | 3,253,183 | |
| 383,376 | Institution | 1.29% | 2,304,090 | |
| 138,080 | Institution | 0.46% | 829,861 | |
| 133,104 | Institution | 0.45% | 799,955 | |
| 74,895 | Institution | 0.25% | 450,119 | |
| 3,521 | Institution | 0.01% | 21,161 | |
| 599 | Institution | <0.01% | 3,600 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 527,690 | Institution | 1.77% | 3,171,417 | |
| 453,810 | Institution | 1.53% | 2,813,622 | |
| 220,073 | Institution | 0.74% | 1,364,453 | |
| 178,994 | Institution | 0.60% | 1,075,754 | |
| 73,766 | Institution | 0.25% | 457,349 | |
| 44,645 | Institution | 0.15% | 268,316 | |
| 18,248 | Institution | 0.06% | 113,138 | |
| 10,622 | Institution | 0.04% | 66,122 | |
| 1,627 | Institution | <0.01% | 10,087 | |
| 889 | Institution | <0.01% | 5,533 |
FAQ
Who Owns Candel Therapeutics (CADL)?
According to the latest TipRanks data, approximately 14.93% of the company's stock is held by institutional investors, 29.37% is held by insiders, and 51.41% is held by retail investors.
What percentage of Candel Therapeutics (CADL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 14.93% of Candel Therapeutics (CADL) stock is held by institutional investors.
What percentage of Candel Therapeutics (CADL) stock is held by retail investors?
According to the latest TipRanks data, approximately 51.41% of Candel Therapeutics (CADL) stock is held by retail investors.
Who owns the most shares of Candel Therapeutics (CADL)?
Vanguard owns the most shares of Candel Therapeutics (CADL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.